NovellusDx's Series C Round

NovellusDx raised a round of funding on April 30, 2018.

NovellusDx is a precision oncology company that has developed a live-cell based assay to monitor the activity of signaling pathways. Using this platform, NovellusDx' solution helps biopharma companies…

Articles about NovellusDx's Series C Round: